Trade of the Day: Inovio Pharmaceuticals Inc (NASDAQ:INO)

To receive further updates on this Inovio Pharmaceuticals Inc (NASDAQ:INO) trade as well as an alert when it’s time to take profits, sign up for a risk-free trial of Momentum Options today.

On Monday, I mentioned that the biotech sector was ripe for a comeback, and I gave you some short-term options to play in the iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) to play it. Today, I want to give you a specific biotech that I’ve been following for some time:  Inovio Pharmaceuticals (INO).

Inovio has nine clinical drugs in development, largely  in Phase 1; as such, the stock carries significant risk. However, because there are no vaccines or treatments for the Zika virus, INO shares  have been moving as the threat grows.

Inovio has been working on a Zika virus vaccine that could be ready for use in late 2016. The organization’s lead developer said Inovio was well ahead of its competition in the race for a vaccine. As we traders know, timing is everything.

Inovio shares traded to a high of $9.49 on Wednesday. The 52-week peak is at $10.83. Support is at $9-$8.75. A “golden cross” has formed, as the 50-day moving average is now above the 200-day moving average. This is typically a bullish setup for higher highs.

Resistance is at $9.75-$10. A close above the latter could lead INO shares toward a run at $11.50-$12. Here’s how I’m trading it:

Buy to open the Inovio May 10 calls (INO160520C00010000) at current levels up to $0.75.

If INO reaches the $11.50 to $12 level by late May, these options will be $1.50-$2 in the money. My exit target for the options is $1.10.

To receive further instructions on this trade, please sign-up for a risk-free, 60-day trial of Momentum Options and take advantage of 50% off the introductory rate for the next three days only.  

10 Triple-Digit Winners… GUARANTEED

While most investors were lucky to break even in 2015, options expert Rick Rouse was racking up another incredible year… 102 total winners, including 18 for triple-digit gains.  That brings his total over the last 8 years to an astonishing 279 triple-digit winners – on top of 494 double-digit wins!  And he’s now GUARANTEEING at least 10 triple-digit winners in 2016 no matter what the market does.  Click here to learn how it does it and see how you can start pocketing triple-digit profits in your portfolio.

 


Article printed from InvestorPlace Media, https://investorplace.com/2016/04/trade-of-the-day-inovio-pharmaceuticals-inc-nasdaq-ino/.

©2021 InvestorPlace Media, LLC